DR. PRITHIPAL S SETHI M.D. NPI 1174710578

NPI Details

DR. Prithipal S Sethi, M.D. is an urology in Sacramento, CA with 27 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. DR. Prithipal S Sethi, M.D. NPI is 1174710578. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

8715 CENTER PKWY
SACRAMENTO, CA
ZIP 95823-921
Phone: (916) 245-8888
Fax: (209) 464-3630

The NPI 1174710578 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The CLIA number assigned to this NPI record is 05D1074973 - physician office with a certificate type of Certificate of Compliance.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, onabotulinumtoxina, 1 unit (HCPCS:J0585)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Detection test by nucleic acid for multiple organisms, amplified probe(s) technique (HCPCS:87801)
• Leuprolide injectable, camcevi, 1 mg (HCPCS:J1952)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique (HCPCS:87500)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Manual urinalysis test with examination using microscope, non-automated (HCPCS:81000)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Simple change of bladder tube (HCPCS:51705)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Cell examination of specimen, concentration technique (HCPCS:88108)
• Insertion of lower leg neurostimulator electrode (HCPCS:64566)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Exam with injections of chemical for destruction of bladder using an endoscope (HCPCS:52287)
• Biopsy of prostate gland (HCPCS:55700)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Complicated change of bladder tube (HCPCS:51710)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99426)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Complicated insertion of bladder tube (HCPCS:51703)
• Injection of biodegradable material next to prostate (HCPCS:55874)
• Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99439)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 9/29/2007 and was last updated on 6/17/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: